Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1622266Generated: November 1, 2026

4-[5-(1-Methanesulfonyl-1,2,3,6-tetrahydro-pyridin-4-yl)-2,3-dihydro-furo[2,3-c]pyridine-2-yl]-piperidine-1-carbonitrile → 5-(1-Methanesulfonyl-1,2,3,6-tetrahydro-pyridin-4-yl)-2-[1-(3-propyl-[1,2,4]oxadiazol-5-yl)-piperidin-4-yl]-2,3-dihydro-furo[2,3-c]pyridine

https://huagongshe.com/reaction/1622266

Reaction equation

Participants

RoleNameHCIDCharge
Reactant4-[5-(1-Methanesulfonyl-1,2,3,6-tetrahydro-pyridin-4-yl)-2,3-dihydro-furo[2,3-c]pyridine-2-yl]-piperidine-1-carbonitrileHCID 86675678—
ReactantHCID 178449909HCID 178449909—
Product5-(1-Methanesulfonyl-1,2,3,6-tetrahydro-pyridin-4-yl)-2-[1-(3-propyl-[1,2,4]oxadiazol-5-yl)-piperidin-4-yl]-2,3-dihydro-furo[2,3-c]pyridineHCID 71208392—

Reaction Steps

The title compound is prepared from 4-[5-(1-methanesulfonyl-1,2,3,6-tetrahydro-pyridin-4-yl)-2,3-dihydro-furo[2,3-c]pyridin-2-yl]-piperidine-1-carbonitrile and N-hydroxy-butyramidine following a procedure analogous to that described in Example 2. LC (method 5): tR=1.02 min; Mass spectrum (ESI+): m/z=474 [M+H]+.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08778926B2
Source datasetuspto-grants-2014_07
ORD IDord-f46e4eaca1b74e52be8796d33cd7c758
Source noteuspto-grants-2014_07